ReviewDrugs1997
A practical guide to the management of complicated urinary tract infection.
Review in Drugs, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02641015 (A Retrospective Observational Study to Assess the Clinical Management and Outcomes of Hospitalised Patients With Complicated Urinary Tract Infection in Countries With High Prevalence of Multidrug Resistant Gram-negative Bacteria.), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Retrospective Observational Study to Assess the Clinical Management and Outcomes of Hospitalised Patients With Complicated Urinary Tract Infection in Countries With High Prevalence of Multidrug Resistant Gram-negative Bacteria.
Who cites it
14 citing papers in PubMed.
- Source Control inOpen forum infectious diseases · 2026Article
- Clinical characteristics and nomogram model for predicting the risk of recurrence of complicated urinary tract infection in pediatric patients.Scientific reports · 2024Article
- [Guideline-based treatment of urinary tract infections].Der Urologe. Ausg. A · 2020Review
- Observational
- For reliable urine cultures in the detection of complicated urinary tract infection, do we use urine specimens obtained with urethral catheter or a nephrostomy tube?Turkish journal of urology · 2016Article
- Observational
- Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study.BMC infectious diseases · 2014Observational
- Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli.Urology annals · 2014Article
- Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.Yonsei medical journal · 2012Article
- Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.Therapeutics and clinical risk management · 2008Article
- An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at The Ottawa Hospital.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2005Article
- Catheter-related urinary tract infection.Drugs & aging · 2005Review
- Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.Drugs · 2004Review
- A practical guide to antimicrobial management of complicated urinary tract infection.Drugs & aging · 2001Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complicated urinary tract infections are infections in the setting of structural or functional abnormalities of the genitourinary tract. They encompass a wide variety of clinical syndromes and anticipated outcomes. The infecting micro-organisms isolated are more varied and demonstrate a higher prevalence of antimicrobial resistance in complicated compared to uncomplicated urinary tract infections. The usual duration of therapy is 7 to 14 days, although comparative trials to define optimal treatment duration are lacking. Long term success of antimicrobial treatment is dependent upon whether or not the underlying genitourinary abnormality can be corrected. Treatment of complicated urinary tract infections will usually be successful and may be permanent if the underlying abnormality can be corrected. If the underlying abnormality cannot be corrected, failure rates of 50% at 4 to 6 weeks following therapy are expected. Antimicrobial agents are similar to those used to treat uncomplicated urinary tract infection. Certain agents, such as nitrofurantoin, should be avoided for individuals with renal failure. No specific agent or class of agents has consistently demonstrated greater therapeutic efficacy where the infecting organism is susceptible to the given agent.
Indexed as
Identifiers
9098661What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.